VIDEO: HOPE-3 trial supports broader role for statins in primary prevention

CHICAGO – The success in the HOPE-3 trial of a two-pronged strategy of a statin plus moderate-dose antihypertensive therapy has expanded the boundaries of primary preventive pharmacotherapy to...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news